Royal Liver's members have voted in favour of its buyout by Royal London.
Members of the mutual life and pensions company approved the deal at its annual general meeting yesterday. Royal Liver will now apply to the FSA for regulatory approval of the transfer, which, subject to approval, will go ahead on 1 July. The two companies signed a transfer agreement in April. When merged, the combined company will have assets of more than £33bn and almost six million customers. Royal Liver suffered serious losses during the recession and has been restructuring since 2009.
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes